Michael Ochse

This inventor holds 39 USPTO granted patents and 8 published patent applications and 11 EPO patents, primarily in Phosphodiesterase Inhibitors. Top assignees: Abbvie Deutschland Gmbh and Co Kg, Abbvie Inc., Abbott Laboratories Corporation. Active years: 2007-2020.

USPTO Granted Patents = 39 (Patent Applications = 8)

% Patents Active = 28.2

EPO Patents = 11 (Patent Applications = 27)

Average Co-Inventor Count = 7.2

ph-index = 7

Forward Citations = 215(Granted Patents)

Location History:

Bad Duerkheim, DE (2007 - 2013)
Weisenheim am Berg, DE (2013)
Weisenheim am Barg, DE (2014)
Bad Durkeim, DE (2014)
Bad Durkheim, DE (2016)
Wiesbaden, DE (2014 - 2017)
Ludwigshafen, DE (2013 - 2020)

Company Filing History:

34 out of 167

Abbvie Deutschland Gmbh and Co Kg

Abbott Laboratories Corporation

Basf Aktiengesellschaft

patents

where one patent can have more than one assignee

Years Active: 2007-2020

Loading Chart...

Areas of Expertise:

Phosphodiesterase Type 10A

Isoquinolines

Heterocyclic Compounds

Pyrazolopyrimidines

Therapeutic Compositions

Binding Partners

Guanidine Compounds

Aminoindane Derivatives

Phenalkylamine Derivatives

Fused Compounds

Isoxazolopyridazinones

Tetraline Derivatives

39 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10556914 - Substituted isoxazolopyridazinones and isothiazolopyridazinones and methods of use (2020-02-11),

2. 10556907 - Fused heterocyclic compounds as S1P modulators (2020-02-11),

3. 10308610 - Inhibitor compounds of phosphodiesterase type 10A (2019-06-04),

4. 10280159 - Fused (hetero)cyclic compounds as S1P modulators (2019-05-07),

5. 10155770 - Substituted pyrazolopyrimidines and method of use (2018-12-18),

6. 9938269 - Inhibitor compounds of phosphodiesterase type 10A (2018-04-10),

7. 9856220 - Inhibitor compounds of phosphodiesterase type 10A (2018-01-02),

8. 9828381 - Substituted pyrazolopyrimidines and method of use (2017-11-28),

9. 9790203 - Inhibitor compounds of phosphodiesterase type 10A (2017-10-17),

10. 9657034 - Substituted furo[3,2-c]pyridines, thieno[3,2-c]pyridines, thieno[2,3-d]pyridazines and pyrido[3,4-d]pyridazines as phosphodiesterase type 10A inhibitors (2017-05-23),

11. 9475808 - Inhibitor compounds of phosphodiesterase type 10A (2016-10-25),

12. 9475782 - Guanidine compounds, and use thereof as binding partners for 5-HT5 receptors (2016-10-25),

13. 9464085 - Inhibitor compounds of phosphodiesterase type 10A (2016-10-11),

14. 9388180 - Inhibitor compounds of phosphodiesterase type 10A (2016-07-12),

15. 9365512 - Isoindoline derivatives, pharmaceutical compositions containing them, and their use in therapy (2016-06-14),

Title: The Innovative Journey of Michael Ochse

Introduction:

Michael Ochse, a visionary inventor hailing from Ludwigshafen, Germany, has made significant contributions to the world of technology and innovation through his groundbreaking inventions.

Latest Patents:

Michael Ochse's latest patents include a revolutionary smart home automation system that integrates artificial intelligence to enhance energy efficiency and security measures in residential settings.

Career Highlights:

With a career spanning over two decades, Michael Ochse has established himself as a pioneer in the field of sustainable technology. His work on renewable energy solutions has garnered international recognition and praise.

Collaborations:

Throughout his career, Michael Ochse has collaborated with leading research institutions and universities to further advance his innovative ideas. His partnerships have led to the development of cutting-edge technologies that have reshaped various industries.

Conclusion:

In conclusion, Michael Ochse's relentless pursuit of innovation and commitment to creating a more sustainable future have solidified his position as a trailblazer in the world of inventions. His passion for pushing the boundaries of technology continues to inspire the next generation of inventors and innovators.